Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin and Docetaxel in CRPC
NCT04113005Phase 1Unknown
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Oct 2019
- Primary completion
- Apr 2020
- Modality
- Peptides, Small Molecules
01
Overview
Phase 1, open-label trial of desmopressin in prostate cancer (PCa), sponsored by Sunnybrook Health Sciences Centre. Status: unknown.
02
Drugs
desmopressin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04113005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04113005.